Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 133
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 81
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 75
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1263-1321
Closed Access | Times Cited: 53
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 21
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101004-101004
Open Access | Times Cited: 31
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma
Kuo‐Shyang Jeng, Chiung‐Fang Chang, I-Shyang Sheen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1417-1417
Open Access | Times Cited: 26
The role of N-glycosylation modification in the pathogenesis of liver cancer
Mengyu Hu, Rui Zhang, Jiaren Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 23
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
Satoshi Muto, Akio Enta, Yoshiyuki Maruya, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 190-190
Open Access | Times Cited: 20
Morin: A Comprehensive Review on Its Versatile Biological Activity and Associated Therapeutic Potential in Treating Cancers
Balaga Venkata Krishna Rao, A. A. Pradhan, Riya Thapa, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 7, pp. 100264-100264
Open Access | Times Cited: 20
Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target
Zekun Zhao, Tenglu Cui, Fengxian Wei, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction
Marwa M. Abu‐Serie, Satoru Osuka, Lamiaa A Heikal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Wnt/ β-catenin and CTNNB1 gene mutation in hepatocellular carcinoma, a case study in Egyptian patients
Ramy A. Abdelsalam, Ibrahim M. El-Shawaf, Azza Abdel‐Aziz, et al.
Surgical and Experimental Pathology (2025) Vol. 8, Iss. 1
Open Access
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 17
Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
Adriana G. Quiroz-Reyes, Sonia Amelia Lozano Sepúlveda, Natalia Martínez-Acuña, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 15
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 14
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
Anuradha Budhu, Erica C. Pehrsson, Aiwu Ruth He, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101052-101052
Open Access | Times Cited: 14
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 25
Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells
Na Young Kim, In Jin Ha, Jae‐Young Um, et al.
Life Sciences (2023) Vol. 317, pp. 121458-121458
Closed Access | Times Cited: 12
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Julia Pospieszna, Hanna Dams-Kozłowska, Wachirawit Udomsak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10910-10910
Open Access | Times Cited: 11
Withanolide modulates the potential crosstalk between apoptosis and autophagy in different colorectal cancer cell lines
Young Yun Jung, Jae‐Young Um, Arunachalam Chinnathambi, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175113-175113
Closed Access | Times Cited: 19
Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
Rainbow Wing Hei Leung, Terence K. Lee
Cancers (2022) Vol. 14, Iss. 21, pp. 5468-5468
Open Access | Times Cited: 18
Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma
Florian Weber, Oliver Treeck, Patricia Mester, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3473-3473
Open Access | Times Cited: 10
3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma
Chakrabhavi Dhananjaya Mohan, Min Yang, Shobith Rangappa, et al.
Biology (2021) Vol. 11, Iss. 1, pp. 29-29
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top